✦ LIBER ✦

Phase I study of barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumors

✍ Scribed by Gary K. Schwartz,Richard D. Carvajal,Rachel Midgley…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I study to assess the safety, ph

✍ Kosuke Tsuboi; Toshiya Yokozawa; Toru Sakura; Takashi Watanabe; Shin Fujisawa; T 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Phase I study of the Aurora B kinase inh

✍ Mike Dennis, Michelle Davies, Stuart Oliver… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 328 KB

Phase 1 study of MLN8054, a selective in

✍ E. Claire Dees; Jeffrey R. Infante; Roger B. Cohen; Bert H. O’Neil; Suzanne Jone 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 328 KB

Phase I dose escalation study of MK-0457

✍ Anne M. Traynor; Maureen Hewitt; Glenn Liu; Keith T. Flaherty; Jason Clark; Stev 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 252 KB

Phase I dose-escalation study of AZD7762

✍ Sausville, Edward; LoRusso, Patricia; Carducci, Michael; Carter, Judith; Quinn, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 560 KB

283 POSTER Phase 1 trial of SNS-314, a n

✍ F. Robert; H. Hurwitz; H. Uronis; C. Verschraegen; R. Advani; A. Chen; G.L. Mess 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 77 KB